IMRN
Immuron Ltd ADR
NASDAQ: IMRN · HEALTHCARE · BIOTECHNOLOGY
$0.82
+1.86% today
Updated 2026-04-30
Market cap
$7.11M
P/E ratio
—
P/S ratio
0.95x
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
6.0
Growth
B5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$4.01
+387.24%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at -62.10%
- Negative free cash flow $-2.43M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $765193.00 | $1.80M | $4.90M | $7.29M | $7.48M |
| Net income | $-2.85M | $-3.79M | $-6.94M | $-5.22M | $-1.88M |
| EPS | — | — | — | — | $-0.53 |
| Free cash flow | $-3.14M | $-2.50M | $-5.88M | $-6.14M | $-2.43M |
| Profit margin | -373.01% | -209.81% | -141.49% | -71.58% | -62.10% |
Peer comparison
Smart narrative
Immuron Ltd ADR trades at $0.82. Our Smart Value Score of 33/100 indicates the stock is weak. TTM revenue stands at $7.48M. with profit margins at -62.10%.
Frequently asked questions
What is Immuron Ltd ADR's stock price?
Immuron Ltd ADR (IMRN) trades at $0.82.
Is Immuron Ltd ADR overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell).
What is the price target of Immuron Ltd ADR (IMRN)?
The analyst target price is $4.01, representing +387.2% upside from the current price of $0.82.
What is Immuron Ltd ADR's revenue?
TTM revenue is $7.48M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.95x
ROE-39.70%
Beta0.36
50D MA$0.80
200D MA$1.37
Shares out0.01B
Float0.32B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—